China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China · Delayed Price · Currency is CNY 25.78
+0.04 (0.16%)
Mar 19, 2026, 1:24 PM CST
SHA:600750 Market Cap
SHA:600750 has a market cap or net worth of 16.2 billion as of March 18, 2026. Its market cap has increased by 18.32% in one year.
Market Cap
16.20B
Enterprise Value
14.75B
Revenue
4.24B
Ranking
n/a
PE Ratio
19.79
Stock Price
25.78
Market Cap Chart
Since January 2, 2001, SHA:600750's market cap has increased from 2.58B to 16.20B, an increase of 528.98%. That is a compound annual growth rate of 7.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 16.03B | 10.04% |
| Dec 31, 2025 | 14.57B | 3.07% |
| Dec 31, 2024 | 14.14B | 8.64% |
| Dec 29, 2023 | 13.01B | 44.47% |
| Dec 30, 2022 | 9.01B | -0.07% |
| Dec 31, 2021 | 9.01B | 34.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Dongbao Pharmaceutical | 17.51B |
| Hybio Pharmaceutical | 16.13B |
| Nanjing King-Friend Biochemical Pharmaceutical | 16.03B |
| Shenzhen Kangtai Biological Products | 15.91B |
| Guangdong Zhongsheng Pharmaceutical | 15.51B |
| Guobang Pharma | 15.34B |
| Shenzhen Hepalink Pharmaceutical Group | 15.20B |
| Zhejiang Medicine | 15.12B |